Low-Flow Anaesthesia

Low-flow anaesthesia:

Advantages of Low-Flow Anaesthesia

Benefits include:

  • Clinical
    • Measurement of oxygen consumption
      Can be estimated by comparing FGF requirements to circuit volume.
    • ↑ humidification
      Rebreathing ↑ humidity, ↓ mucociliary impairment.
    • Temperature
      Rebreathing increaeses temperature of inspired gases, ↓ heat loss under anaesthesia. This can be substantial - up to 1°C in core body temperature after 1 hour of anaesthesia.
  • Environmental
    Inhalational anaesthetic agents are potent greenhouse gases. ↓ FGF results in ↓ volatile consumption, and therefore emission of inhalational agents.
  • Economic
    ↓ use of inhalational agents ↓ the cost of delivering anesthesia.

Disadvantages of Low-Flow Anaesthesia

Disadvantages include:

  • Circuit gas composition does not correspond to FGF composition
    Change in circuit gas composition will depend on the time-constant of the circuit.
    • Remember that for an anaesthetic circuit \[\tau = {Circuit Volume \over FGF - Patient \ Gas \ Uptake}\]
      A process will be 95% complete at the end of three time-constants.
      • At low flows, the time-constant for equilibration between the circuit and the FGF gas ↑
        Results in very slow equilibration between the circuit/patient and the delivered gas.
      • E.g., for a 5L circuit + FRC volume, ↑ the FGF to 5L/min will see circuit gas composition approximate FGF composition in ~3 minutes
  • Risk of hypoxia
    If oxygen consumption exceeds oxygen delivery:
    • Circuit volume will ↓
      As the overall volume of gas has ↓.
    • Circuit mixture will become relatively hypoxic
      Oxygen is consumed, however nitrogen and inhalational agent amounts remain constant; this results in a ↓ FiO2.
  • ↑ soda-lime concentration
    As less CO2 will be scavenged, soda-lime consumption will ↑.
  • Loss of circuit volume
    Indicated by ↓ in minute ventilation, peak airway pressure, and collapse of the bellows or resevoir bag.
    • FGF to overcome leak
    • Search for source of leak

Contraindications to Low-Flow Anaesthesia

Contraindications include:

  • Toxic gases
    Adequate FGF must be used to ensure washout of toxic gases.
  • Smoke inhalation
    • Carbon monoxide
  • Cyanide toxicity
  • Malignant hyperthermia
    As volatile agents will be ceased, there is no benefit to low-flow techniques. Additionally, high FGF is required to ensure adequate washout of CO2.
  • Alcohol intoxication
    Prevents pulmonary clearance of gaseous alcohol.
  • Acetone poisoning
    • Prolongs anaesthesia
    • ↑ PONV
  • Ketoacidosis
    In severe cases, may lead to accumulation of gaseous acetone in the circuit.

Performing Low-Flow Anaesthesia

  • Technical requirements
    • End-tidal gas measurement
      As end-tidal agent concentration will differ markedly from delivered agent concentration, closed-loop monitoring must be used.
    • Free of circuit leaks
  • Estimate VO2
    • VO2 can be crudely measured using the Brody Formula: \[ VO_2 = 3.5 \times kg\]
      This typically overestimates consumption by 10-20%, which introduces a margin of safety.
  • Set an FiO2 alarm
    e.g. 30%.
  • Deliver a volume of gas greater than the patients oxygen consumption
    At minimal-flows, it easier (and safter with respect to hypoxia) to use 100% oxygen as the carrier gas to prevent buildup of nitrogen and delivery of a hypoxic gas mixture; although over time this will cause FiO2 to steadily ↑.
  • Use an insoluble agent if possible
    Desflurane and sevoflurane are better agents for use with low-flow techniques due to their shorter time constants.

Template for Low-Flow Anaesthesia with Oxygen and Air

  • Standard Induction
  • Initial Phase
    • FGF of 4L/min with 40% FiO2
      3L/min air, 1L/min O2; will lead to an FiO2 of 35-40%.
    • Vaporiser:
      • Sevoflurane 3.5%
      • Isoflurane 2.5%
      • Desflurane 6%
  • At target MAC (0.8-1)
    • FGF to 0.5L/min with 68% FiO2
      0.3L/min air, 0.2L/min O2.
    • ↑ vaporiser:
      • Sevoflurane 5%
      • Isoflurane 5%
      • Desflurane 8%
  • Adjusting
    • Rapid change in agent concentration:
      • Set vaporiser to 0.5-1% above target concentration
      • FGF to 4L/min
    • Slow ↑ in agent concentration:
      • Continue FGF at 0.5L/min
      • ↑ vaporiser by 1-2% or higher
      • At target, leave vaporiser 0.5-1% higher than target
    • Slow ↓ in agent concentration:
      • Continue FGF at 0.5L/min
      • Reduce vaporiser by 1-3.5%
      • At target, ↑ the vaporiser to its previous setting
  • Reversal
    • Set vaporiser to 0% ~10 minutes prior to end of operation
    • Continue FGF at 0.5L/min
    • Begin spontaneous ventilation
    • At the last suture, purge system with 100% O2 at 6L/min
      ↑ the FGF above this does not appreciably ↓ the time for washout, as at 6L/min rebreathing fraction is only ~2.5%.

Template for Minimal-Flow Anaesthesia with Oxygen and Nitrous Oxide

  • Standard induction
  • Initial Phase
    • FGF of 4.4L/min with 32% FiO2
      1.4L/min O2 and 3L/min N2O; will lead to an FiO2 of 30-40%.
    • Vaporiser:
      • Sevoflurane 2-2.5%
      • Isoflurane 1-1.5%
      • Desflurane 4-6%
  • At target MAC (0.8-1)
    • Reduce FGF to 0.5L/min (0.3L/min O2 and 0.2L/min N2O)
    • ↑ vaporiser:
      • Sevoflurane 3-3.5%
      • Isoflurane 2.5%
      • Desflurane 5-7.5%
  • Adjusting
    • Rapid change in agent concentration:
      • Set vaporiser to 0.5% above target concentration
      • FGF to 4.4L/min
      • At target, reduce the FGF to 0.5 L/min
    • Slow ↑ in agent concentration
      • Continue FGF at 0.5L/min
      • ↑ vaporiser by 1-2% or higher
      • At target, set vaporiser to 0.5-1% higher than target
    • Slow ↓ in agent concentration
      • Continue FGF at 0.5L/min
      • ↓ vaporiser by 1-3.5%
      • At target, ↑ vaporiser to its previous setting
  • Reversal
    • Set vaporiser to 0% ~10-15 minutes prior to end of operation
    • Continue FGF at 0.5L/min
    • Begin spontaneous ventilation
    • At the last suture, purge the system with 100% O2 at 6L/min

References

  1. Hönemann C, Mierke B. Low-flow, minimal-flow and metabolic-flow anaesthesia: Clinical techniques for use with rebreathing systems. Drägerwerk AG & Co., Lübeck, Germany.